Department of Radiation Oncology
Eddy S. Yang has not added Biography.
If you are Eddy S. Yang and would like to personalize this page please email our Author Liaison for assistance.
Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer.
Molecular and cellular endocrinology Jan, 2002 | Pubmed ID: 11850123
Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm.
The Journal of biological chemistry Nov, 2003 | Pubmed ID: 12954644
Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells.
Oncogene Jul, 2004 | Pubmed ID: 15077174
Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy Aug-Oct, 2007 | Pubmed ID: 17627865
The role of mTOR inhibition in augmenting radiation induced autophagy.
Technology in cancer research & treatment Oct, 2007 | Pubmed ID: 17877432
Evolution of clinical trials in head and neck cancer.
Critical reviews in oncology/hematology Jul, 2009 | Pubmed ID: 18996026
Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells.
Cancer research Nov, 2008 | Pubmed ID: 19010885
Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice.
The Journal of clinical investigation May, 2009 | Pubmed ID: 19425167
Refractory lympho-epithelial carcinoma of the nasopharynx: a case report illustrating a protracted clinical course.
Head & neck oncology , 2009 | Pubmed ID: 19527509
Reduction of dose delivered to organs at risk in prostate cancer patients via image-guided radiation therapy.
International journal of radiation oncology, biology, physics Mar, 2010 | Pubmed ID: 20004528
BRCA1 16 years later: DNA damage-induced BRCA1 shuttling.
The FEBS journal Aug, 2010 | Pubmed ID: 20608971
DNA damage-induced cytotoxicity is dissociated from BRCA1's DNA repair function but is dependent on its cytosolic accumulation.
Cancer research Aug, 2010 | Pubmed ID: 20631074
Glycogen synthase kinase 3beta inhibition enhances repair of DNA double-strand breaks in irradiated hippocampal neurons.
Neuro-oncology May, 2011 | Pubmed ID: 21398658
Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Jun, 2011 | Pubmed ID: 21704410
The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Jun, 2011 | Pubmed ID: 21719137
Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Oct, 2011 | Pubmed ID: 21722984
Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert study.
Physics in medicine and biology Jul, 2011 | Pubmed ID: 21725140
p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage.
Cancer research Aug, 2011 | Pubmed ID: 21742769
Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer.
PloS one , 2011 | Pubmed ID: 21912620
Emerging roles of glycogen synthase kinase 3 in the treatment of brain tumors.
Frontiers in molecular neuroscience , 2011 | Pubmed ID: 22275880
Kinomic profiling approach identifies Trk as a novel radiation modulator.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Jun, 2012 | Pubmed ID: 22561027
MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.
Clinical cancer research : an official journal of the American Association for Cancer Research Jun, 2012 | Pubmed ID: 22619307
Epigenetic inactivation of DNA repair in breast cancer.
Cancer letters May, 2012 | Pubmed ID: 22634493
Targeting BRCA1 Localization to Augment Breast Tumor Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition.
Cancer research Nov, 2012 | Pubmed ID: 22962264
Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry.
Prostate cancer , 2012 | Pubmed ID: 22966463
HER2 overexpression renders human breast cancers sensitive to PARP inhibition independently of any defect in homologous recombination DNA repair.
Cancer research Sep, 2012 | Pubmed ID: 22987487
Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells.
PloS one , 2012 | Pubmed ID: 23071597
Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2012 | Pubmed ID: 23147994
1Department of Radiation Oncology, University of Alabama-Birmingham,
2Department of Radiation Oncology, The Ohio State University Medical School,
3Department of Cell Biology, and Pharmacology and Toxicology, Comprehensive Cancer Center, University of Alabama at Birmingham School of Medicine, University of Alabama-Birmingham